#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5225583	B	Inhibition of mPGES-1 activity in IL-1beta stimulated human A549 microsomal preparation using PGH2 as substrate assessed as inhibition of PGE2 synthesis by measuring residual activity at 10 uM preincubated for 15 mins followed by substrate addition and measured after 1 min by RP-HPLC analysis relative to control	Homo sapiens	9	ALA5223158	microsome format	Scientific Literature
2.	ALA5225584	B	Inhibition of mPGES-1 activity in IL-1beta stimulated human A549 microsomal preparation using PGH2 as substrate assessed as inhibition of PGE2 synthesis preincubated for 15 mins followed by substrate addition and measured after 1 min by RP-HPLC analysis	Homo sapiens	9	ALA5223158	microsome format	Scientific Literature
3.	ALA5225585	B	Inhibition of ovine COX-1 using arachidonic acid as substrate assessed as reduction in 12-HHT formation by measuring residual activity at 10 uM preincubated for 5 mins followed by substrate addition and measured after 5 mins by RP-HPLC analysis relative to control	Ovis aries	4	ALA5223158	single protein format	Scientific Literature
4.	ALA5225586	B	Inhibition of human COX-2 using arachidonic acid as substrate assessed as reduction in 12-HHT formation by measuring residual activity at 10 uM preincubated for 5 mins followed by substrate addition and measured after 5 mins by RP-HPLC analysis relative to control	Homo sapiens	4	ALA5223158	single protein format	Scientific Literature
5.	ALA5225587	B	Inhibition of human recombinant 5-LO expressed in Escherichia coli BL21 using arachidonic acid as substrate assessed as residual activity at 10 uM preincubated for 10 mins followed by substrate addition and measured after 10 mins by RP-HPLC analysis relative to control	Homo sapiens	2	ALA5223158	assay format	Scientific Literature
6.	ALA5225589	B	Inhibition of recombinant human sEH expressed in baculovirus infected Sf9 cells using PHOME as substrate assessed as residual activity at 10 uM preincubated for 15 mins followed by substrate addition and measured after 60 mins by spectrofluorimetric method relative to control	Homo sapiens	4	ALA5223158	cell-based format	Scientific Literature
7.	ALA5225591	F	Inhibition of Leukotriene biosynthesis in human PMNL cells preincubated for 10 mins followed by Ca2+-ionophore A23187 addition and measured after 10 mins by RP-HPLC analysis	Homo sapiens	4	ALA5223158	cell-based format	Scientific Literature
8.	ALA5225592	F	Inhibition of Leukotriene biosynthesis in human PMNL cells preincubated for 10 mins followed by Ca2+-ionophore A23187 and arachidonic acid addition and measured after 10 mins by RP-HPLC analysis	Homo sapiens	4	ALA5223158	cell-based format	Scientific Literature
9.	ALA5225593	F	Inhibition of 5-LO product formation in Staphylococcus aureus activated human monocyte derived macrophages at 10 uM preincubated for 15 mins followed by Staphylococcus aureus activation for 90 mins by UPLC-MS/MS analysis	Homo sapiens	5	ALA5223158	cell-based format	Scientific Literature
10.	ALA5225594	F	Modulation of IL-6 production in LPS-stimulated mouse J774.A1 cells at 1 uM incubated for 24 hrs by ELISA	Mus musculus	2	ALA5223158	cell-based format	Scientific Literature
11.	ALA5225595	F	Modulation of PGE2 production in LPS-stimulated mouse J774.A1 cells at 1 uM incubated for 24 hrs by ELISA	Mus musculus	2	ALA5223158	cell-based format	Scientific Literature
12.	ALA5225596	F	Anti-inflammatory activity against CD-1 mouse model of zymosan-induced peritonitis assessed as reduction in leucocyte recruitment in lavage fluid at 1 to 10 mg/kg, ip pretreated with zymosan for 30 mins followed by compound addition and measured after 4 to 24 hrs by TC10 automated cell counter analysis	Mus musculus	1	ALA5223158	organism-based format	Scientific Literature
13.	ALA5225598	F	Anti-inflammatory activity against CD-1 mouse model of zymosan-induced peritonitis assessed as reduction in IL-1beta level at 10 mg/kg, ip pretreated with zymosan for 30 mins followed by compound addition and measured after 4 to 24 hrs by ELISA	Mus musculus	1	ALA5223158	organism-based format	Scientific Literature
14.	ALA5225599	F	Anti-inflammatory activity against CD-1 mouse model of zymosan-induced peritonitis assessed as reduction in IL-6 level at 10 mg/kg, ip pretreated with zymosan for 30 mins followed by compound addition and measured after 4 to 24 hrs by ELISA	Mus musculus	1	ALA5223158	organism-based format	Scientific Literature
15.	ALA5225600	F	Anti-inflammatory activity against CD-1 mouse model of zymosan-induced peritonitis assessed as reduction in PGE2 level at 10 mg/kg, ip pretreated with zymosan for 30 mins followed by compound addition and measured after 4 to 24 hrs by ELISA	Mus musculus	1	ALA5223158	organism-based format	Scientific Literature
16.	ALA5225601	F	Anti-inflammatory activity against CD-1 mouse model of zymosan-induced peritonitis assessed as reduction in IL-10 level at 10 mg/kg, ip pretreated with zymosan for 30 mins followed by compound addition and measured after 24 hrs by ELISA	Mus musculus	1	ALA5223158	organism-based format	Scientific Literature